<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>

<channel>
	<title>Medical Sales Jobs Websites</title>
	<atom:link href="http://medical-sales-jobs-websites.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://medical-sales-jobs-websites.com</link>
	<description>Medical Sales Jobs &#124; Laboratory Sales Jobs &#124; Medical Device Sales Jobs</description>
	<pubDate>Fri, 19 Mar 2010 14:02:52 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.1</generator>
	<language>en</language>
			<item>
		<title>Medtronic Receives FDA Panel&#8217;s Unanimous Recommendation for Approval of Revo MRI SureScan Pacing System</title>
		<link>http://medical-sales-jobs-websites.com/2010/03/medtronic-receives-fda-panels-unanimous-recommendation-for-approval-of-revo-mri-surescan-pacing-system/</link>
		<comments>http://medical-sales-jobs-websites.com/2010/03/medtronic-receives-fda-panels-unanimous-recommendation-for-approval-of-revo-mri-surescan-pacing-system/#comments</comments>
		<pubDate>Fri, 19 Mar 2010 14:02:52 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Medical Sales Jobs]]></category>

		<guid isPermaLink="false">http://medical-sales-jobs-websites.com/medtronic-receives-fda-panels-unanimous-recommendation-for-approval-of-revo-mri-surescan-pacing-system</guid>
		<description><![CDATA[Positive Step Toward the First Pacemaker System Approval in the United States for Use in the MRI Environment MINNEAPOLIS--(HSMN NewsFeed)--Medtronic, Inc. (NYSE:MDT ) today announced that the U.S. Food and Drug Administration (FDA) Circulatory System De... <br/><font color="red">Devices, Cardiology</font><br/><font color="blue">Medtronic, Revo MRI, SureScan, pacemaker</font> ]]></description>
			<content:encoded><![CDATA[<p>Positive Step Toward the First Pacemaker System Approval in the United States for Use in the MRI Environment MINNEAPOLIS&#8211;(HSMN NewsFeed)&#8211;Medtronic, Inc. (NYSE:MDT ) today announced that the U.S. Food and Drug Administration (FDA) Circulatory System De&#8230; <br/><font color="red">Devices, Cardiology</font><br/><font color="blue">Medtronic, Revo MRI, SureScan, pacemaker</font>
</p>
<h3><a href="			">Medtronic Receives FDA Panel&#8217;s Unanimous Recommendation for Approval of Revo MRI SureScan Pacing System<br />
			</a></h3>
]]></content:encoded>
			<wfw:commentRss>http://medical-sales-jobs-websites.com/2010/03/medtronic-receives-fda-panels-unanimous-recommendation-for-approval-of-revo-mri-surescan-pacing-system/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Astellas Announces Changes to Director Nominees for Election to OSI Pharmaceuticals&#8217; Board of Directors</title>
		<link>http://medical-sales-jobs-websites.com/2010/03/astellas-announces-changes-to-director-nominees-for-election-to-osi-pharmaceuticals-board-of-directors/</link>
		<comments>http://medical-sales-jobs-websites.com/2010/03/astellas-announces-changes-to-director-nominees-for-election-to-osi-pharmaceuticals-board-of-directors/#comments</comments>
		<pubDate>Fri, 19 Mar 2010 12:54:26 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Medical Sales Jobs]]></category>

		<guid isPermaLink="false">http://medical-sales-jobs-websites.com/astellas-announces-changes-to-director-nominees-for-election-to-osi-pharmaceuticals-board-of-directors</guid>
		<description><![CDATA[TOKYO, March Nineteen (HSMN NewsFeed) -- Astellas Pharma Inc. (TSE:4503.to ) today notified OSI Pharmaceuticals Inc. (Nasdaq:OSIP ) that John D. Gilly, Ph.D. and Margaret T. Monaco will replace Jack Kaye and Heidi L. Steiger on the slate of directors Astellas... <br/><font color="red">Biopharmaceuticals, Mergers &#038; Acquisitions, Personnel</font><br/><font color="blue">Astellas Pharmaceutical, OSI Pharmaceuticals</font> ]]></description>
			<content:encoded><![CDATA[<p>TOKYO, March 19 (HSMN NewsFeed) &#8212; Astellas Pharmaceutical Inc. (TSE:4503.to ) today notified OSI Pharmaceuticals Inc. (Nasdaq:OSIP ) that John D. Gilly, Ph.D. and Margaret T. Monaco will replace Jack Kaye and Heidi L. Steiger on the slate of directors Astellas&#8230; <br/><font color="red">Biopharmaceuticals, Mergers &#038; Acquisitions, Personnel</font><br/><font color="blue">Astellas Pharmaceutical, OSI Pharmaceuticals</font>
</p>
<h3><a href="			">Astellas Announces Changes to Director Nominees for Election to OSI Pharmaceuticals&#8217; Board of Directors<br />
			</a></h3>
]]></content:encoded>
			<wfw:commentRss>http://medical-sales-jobs-websites.com/2010/03/astellas-announces-changes-to-director-nominees-for-election-to-osi-pharmaceuticals-board-of-directors/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Levact(R) (bendamustine) Recommended for Approval in Europe for Treating Blood Cancers</title>
		<link>http://medical-sales-jobs-websites.com/2010/03/levactr-bendamustine-recommended-for-approval-in-europe-for-treating-blood-cancers/</link>
		<comments>http://medical-sales-jobs-websites.com/2010/03/levactr-bendamustine-recommended-for-approval-in-europe-for-treating-blood-cancers/#comments</comments>
		<pubDate>Fri, 19 Mar 2010 11:25:03 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Medical Sales Jobs]]></category>

		<guid isPermaLink="false">http://medical-sales-jobs-websites.com/levactr-bendamustine-recommended-for-approval-in-europe-for-treating-blood-cancers</guid>
		<description><![CDATA[CAMBRIDGE, England, March 19, 2010 (HSMN NewsFeed) -- Mundipharma announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending that product management authorisatio... <br/><font color="red">Biopharmaceuticals, Oncology, Regulatory</font><br/><font color="blue">Mundipharma, Levact, bendamustine, non-Hodgkin's lymphoma, leukemia, myeloma</font> ]]></description>
			<content:encoded><![CDATA[<p>CAMBRIDGE, England, March 19, 2010 (HSMN NewsFeed) &#8212; Mundipharma announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending that product management authorisatio&#8230; <br/><font color="red">Biopharmaceuticals, Oncology, Regulatory</font><br/><font color="blue">Mundipharma, Levact, bendamustine, non-Hodgkin&#8217;s lymphoma, leukemia, myeloma</font>
</p>
<h3><a href="			">Levact(R) (bendamustine) Recommended for Approval in Europe for Treating Blood Cancers<br />
			</a></h3>
]]></content:encoded>
			<wfw:commentRss>http://medical-sales-jobs-websites.com/2010/03/levactr-bendamustine-recommended-for-approval-in-europe-for-treating-blood-cancers/feed/</wfw:commentRss>
		</item>
		<item>
		<title>CNS Response Announces Thompson Board Resignation</title>
		<link>http://medical-sales-jobs-websites.com/2010/03/cns-response-announces-thompson-board-resignation/</link>
		<comments>http://medical-sales-jobs-websites.com/2010/03/cns-response-announces-thompson-board-resignation/#comments</comments>
		<pubDate>Fri, 19 Mar 2010 09:14:01 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Medical Sales Jobs]]></category>

		<guid isPermaLink="false">http://medical-sales-jobs-websites.com/cns-response-announces-thompson-board-resignation</guid>
		<description><![CDATA[ALISO VIEJO, CA--(HSMN NewsFeed) - CNS Response, Inc. (OTC.BB:CNSO ) has announced that Governor Tommy Thompson has resigned from its Board of Directors, and has agreed to become Chairman of its Advisory Board. Thompson told that the resignation was fo... <br/><font color="red">Devices, Neurology, Personalized Medicine, Personnel</font><br/><font color="blue">CNS Response</font> ]]></description>
			<content:encoded><![CDATA[<p>ALISO VIEJO, CA&#8211;(HSMN NewsFeed) - CNS Response, Inc. (OTC.BB:CNSO ) has announced that Governor Tommy Thompson has resigned from its Board of Directors, and has agreed to become Chairman of its Advisory Board. Thompson said that the resignation was fo&#8230; <br/><font color="red">Devices, Neurology, Personalized Medicine, Personnel</font><br/><font color="blue">CNS Response</font>
</p>
<h3><a href="			">CNS Response Announces Thompson Board Resignation<br />
			</a></h3>
]]></content:encoded>
			<wfw:commentRss>http://medical-sales-jobs-websites.com/2010/03/cns-response-announces-thompson-board-resignation/feed/</wfw:commentRss>
		</item>
		<item>
		<title>TranS1 Inc. Announces Appointment of Dwayne Montgomery as Vice President of Sales</title>
		<link>http://medical-sales-jobs-websites.com/2010/03/trans1-inc-announces-appointment-of-dwayne-montgomery-as-vice-president-of-sales/</link>
		<comments>http://medical-sales-jobs-websites.com/2010/03/trans1-inc-announces-appointment-of-dwayne-montgomery-as-vice-president-of-sales/#comments</comments>
		<pubDate>Thu, 18 Mar 2010 09:01:37 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Medical Sales Jobs]]></category>

		<guid isPermaLink="false">http://medical-sales-jobs-websites.com/trans1-inc-announces-appointment-of-dwayne-montgomery-as-vice-president-of-sales</guid>
		<description><![CDATA[WILMINGTON, N.C., March 18, 2010 --(HSMN NewsFeed) -- TranS1 Inc. (Nasdaq:TSON ), a medical device company focused on designing, developing and marketing products that implement its proprietary minimally invasive surgical approach to treat degenerative dis... <br/><font color="red">Devices, Orthopaedic, Neurosurgery, Personnel</font><br/><font color="blue">TranS1, AxiaLIF</font> ]]></description>
			<content:encoded><![CDATA[<p>WILMINGTON, N.C., March 18, 2010 &#8211;(HSMN NewsFeed) &#8212; TranS1 Inc. (Nasdaq:TSON ), a pharma device company focused on designing, developing and marketing products that implement its proprietary minimally invasive surgical approach to treat degenerative dis&#8230; <br/><font color="red">Devices, Orthopaedic, Neurosurgery, Personnel</font><br/><font color="blue">TranS1, AxiaLIF</font>
</p>
<h3><a href="			">TranS1 Inc. Announces Appointment of Dwayne Montgomery as Vice President of Sales<br />
			</a></h3>
]]></content:encoded>
			<wfw:commentRss>http://medical-sales-jobs-websites.com/2010/03/trans1-inc-announces-appointment-of-dwayne-montgomery-as-vice-president-of-sales/feed/</wfw:commentRss>
		</item>
		<item>
		<title>King Pharmaceuticals Announces US Department of Justice Settlement</title>
		<link>http://medical-sales-jobs-websites.com/2010/03/king-pharmaceuticals-announces-us-department-of-justice-settlement/</link>
		<comments>http://medical-sales-jobs-websites.com/2010/03/king-pharmaceuticals-announces-us-department-of-justice-settlement/#comments</comments>
		<pubDate>Wed, 17 Mar 2010 22:04:19 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Medical Sales Jobs]]></category>

		<guid isPermaLink="false">http://medical-sales-jobs-websites.com/king-pharmaceuticals-announces-us-department-of-justice-settlement</guid>
		<description><![CDATA[BRISTOL, TN--(HSMN NewsFeed) - King Pharmaceuticals, Inc. (NYSE:KG ) today announced that its subsidiaries, Alpharma Inc. and Alpharma Pharmaceuticals LLC (&#34;Alpharma&#34;), have finalized a civil settlement with the United States Department of Justic... <br/><font color="red">Biopharmaceuticals</font><br/><font color="blue">King Pharmaceuticals, Alpharma, Kadian, morphine</font> ]]></description>
			<content:encoded><![CDATA[<p>BRISTOL, TN&#8211;(HSMN NewsFeed) - King Pharmaceuticals, Inc. (NYSE:KG ) today announced that its subsidiaries, Alpharma Inc. and Alpharma Pharmaceuticals LLC (&quot;Alpharma&quot;), have finalized a civil settlement with the United States Department of Justic&#8230; <br/><font color="red">Biopharmaceuticals</font><br/><font color="blue">King Pharmaceuticals, Alpharma, Kadian, morphine</font>
</p>
<h3><a href="			">King Pharmaceuticals Announces US Department of Justice Settlement<br />
			</a></h3>
]]></content:encoded>
			<wfw:commentRss>http://medical-sales-jobs-websites.com/2010/03/king-pharmaceuticals-announces-us-department-of-justice-settlement/feed/</wfw:commentRss>
		</item>
		<item>
		<title>FDA Approves First of Its Kind, Fully Implantable (Surgically), Invisible, Prosthetic Hearing Restoration Device</title>
		<link>http://medical-sales-jobs-websites.com/2010/03/fda-approves-first-of-its-kind-fully-implantable-surgically-invisible-prosthetic-hearing-restoration-device/</link>
		<comments>http://medical-sales-jobs-websites.com/2010/03/fda-approves-first-of-its-kind-fully-implantable-surgically-invisible-prosthetic-hearing-restoration-device/#comments</comments>
		<pubDate>Wed, 17 Mar 2010 21:25:17 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Medical Sales Jobs]]></category>

		<guid isPermaLink="false">http://medical-sales-jobs-websites.com/fda-approves-first-of-its-kind-fully-implantable-surgically-invisible-prosthetic-hearing-restoration-device</guid>
		<description><![CDATA[MINNEAPOLIS, March 17 (HSMN NewsFeed) -- On March 17, 2010 the FDA gave approval to Envoy Clinical Corporation to market a &#34;First of its Kind&#34; prosthetic hearing restoration device. The approval follows a December 18, 2009 unanimous Fifteen to 0 vote... <br/><font color="red">Devices, FDA</font><br/><font color="blue">Envoy Pharmaceutical</font> ]]></description>
			<content:encoded><![CDATA[<p>MINNEAPOLIS, March 17 (HSMN NewsFeed) &#8212; On March 17, 2010 the FDA gave approval to Envoy Clinical Corporation to market a &quot;First of its Kind&quot; prosthetic hearing restoration device. The approval follows a December 18, 2009 unanimous 15 to 0 vote&#8230; <br/><font color="red">Devices, FDA</font><br/><font color="blue">Envoy Medical</font>
</p>
<h3><a href="			">FDA Approves First of Its Kind, Fully Implantable (Surgically), Invisible, Prosthetic Hearing Restoration Device<br />
			</a></h3>
]]></content:encoded>
			<wfw:commentRss>http://medical-sales-jobs-websites.com/2010/03/fda-approves-first-of-its-kind-fully-implantable-surgically-invisible-prosthetic-hearing-restoration-device/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Boston Scientific Completes Enrollment in PLATINUM Trials for Diminutive Vessels and Long Lesions</title>
		<link>http://medical-sales-jobs-websites.com/2010/03/boston-scientific-completes-enrollment-in-platinum-trials-for-small-vessels-and-long-lesions/</link>
		<comments>http://medical-sales-jobs-websites.com/2010/03/boston-scientific-completes-enrollment-in-platinum-trials-for-small-vessels-and-long-lesions/#comments</comments>
		<pubDate>Tue, 16 Mar 2010 13:22:33 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Medical Sales Jobs]]></category>

		<guid isPermaLink="false">http://medical-sales-jobs-websites.com/boston-scientific-completes-enrollment-in-platinum-trials-for-small-vessels-and-long-lesions</guid>
		<description><![CDATA[Trials to evaluate small vessel and long lesion versions of platinum chromium PROMUS(R) Element(TM) Stent System NATICK, Mass., March 16 (HSMN NewsFeed) -- Boston Scientific Corporation (NYSE:BSX ) today announced the completion of patient enrollment ... <br/><font color="red">Devices, Interventional Cardiology</font><br/><font color="blue">Boston Scientific, platinum chromium, PROMUS Element, drug eluting stent</font> ]]></description>
			<content:encoded><![CDATA[<p>Trials to evaluate small vessel and long lesion versions of platinum chromium PROMUS(R) Element(TM) Stent System NATICK, Mass., March 16 (HSMN NewsFeed) &#8212; Boston Scientific Corporation (NYSE:BSX ) today announced the completion of patient enrollment &#8230; <br/><font color="red">Devices, Interventional Cardiology</font><br/><font color="blue">Boston Scientific, platinum chromium, PROMUS Element, drug eluting stent</font>
</p>
<h3><a href="			">Boston Scientific Completes Enrollment in PLATINUM Trials for Small Vessels and Long Lesions<br />
			</a></h3>
]]></content:encoded>
			<wfw:commentRss>http://medical-sales-jobs-websites.com/2010/03/boston-scientific-completes-enrollment-in-platinum-trials-for-small-vessels-and-long-lesions/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Caris Life Sciences Announces Two Senior Vice President Appointments</title>
		<link>http://medical-sales-jobs-websites.com/2010/03/caris-life-sciences-announces-two-senior-vice-president-appointments/</link>
		<comments>http://medical-sales-jobs-websites.com/2010/03/caris-life-sciences-announces-two-senior-vice-president-appointments/#comments</comments>
		<pubDate>Tue, 16 Mar 2010 13:06:35 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Medical Sales Jobs]]></category>

		<guid isPermaLink="false">http://medical-sales-jobs-websites.com/caris-life-sciences-announces-two-senior-vice-president-appointments</guid>
		<description><![CDATA[IRVING, Texas, March 16, 2010 --(HSMN NewsFeed) -- Caris Life Sciences, Inc. -- a top biosciences company focused on enabling precise and personalized healthcare through the highest quality anatomic laboratory, molecular profiling, and blood-based diagn... <br/><font color="red">Personalized Medicine, Diagnostics, Personnel</font><br/><font color="blue">Caris Life Sciences</font> ]]></description>
			<content:encoded><![CDATA[<p>IRVING, Texas, March 16, 2010 &#8211;(HSMN NewsFeed) &#8212; Caris Life Sciences, Inc. &#8212; a top biosciences company focused on enabling precise and personalized healthcare through the highest quality anatomic clinical laboratory, molecular profiling, and blood-based diagn&#8230; <br/><font color="red">Personalized Medicine, Diagnostics, Personnel</font><br/><font color="blue">Caris Life Sciences</font>
</p>
<h3><a href="			">Caris Life Sciences Announces Two Senior Vice President Appointments<br />
			</a></h3>
]]></content:encoded>
			<wfw:commentRss>http://medical-sales-jobs-websites.com/2010/03/caris-life-sciences-announces-two-senior-vice-president-appointments/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Philips Simplifies Cardiology Care With Technologies That Span the Entire Spectrum of Patient Care</title>
		<link>http://medical-sales-jobs-websites.com/2010/03/philips-simplifies-cardiology-care-with-technologies-that-span-the-entire-spectrum-of-patient-care/</link>
		<comments>http://medical-sales-jobs-websites.com/2010/03/philips-simplifies-cardiology-care-with-technologies-that-span-the-entire-spectrum-of-patient-care/#comments</comments>
		<pubDate>Mon, 15 Mar 2010 20:27:48 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Medical Sales Jobs]]></category>

		<guid isPermaLink="false">http://medical-sales-jobs-websites.com/philips-simplifies-cardiology-care-with-technologies-that-span-the-entire-spectrum-of-patient-care</guid>
		<description><![CDATA[ATLANTA, March Fifteen (HSMN NewsFeed) -- At this year's annual meeting of the American College of Cardiology (ACC), March 14-16 in Atlanta, Royal Philips Electronics (NYSE: PHG, AEX: PHI) will showcase its commitment to simplifying cardiology patient care by... <br/><font color="red">Devices, Cardiology, Monitoring</font><br/><font color="blue">Royal Philips Electronics, Hybrid OR , InnerCool</font> ]]></description>
			<content:encoded><![CDATA[<p>ATLANTA, March 15 (HSMN NewsFeed) &#8212; At this year&#8217;s annual meeting of the American College of Cardiology (ACC), March 14-16 in Atlanta, Royal Philips Electronics (NYSE: PHG, AEX: PHI) will showcase its commitment to simplifying cardiology patient care by&#8230; <br/><font color="red">Devices, Cardiology, Monitoring</font><br/><font color="blue">Royal Philips Electronics, Hybrid OR , InnerCool</font>
</p>
<h3><a href="			">Philips Simplifies Cardiology Care With Technologies That Span the Entire Spectrum of Patient Care<br />
			</a></h3>
]]></content:encoded>
			<wfw:commentRss>http://medical-sales-jobs-websites.com/2010/03/philips-simplifies-cardiology-care-with-technologies-that-span-the-entire-spectrum-of-patient-care/feed/</wfw:commentRss>
		</item>
	</channel>
</rss>
